1/Welcome to the #CGAIGCJS Tweetorial on “Long-Term, Prospective Assessment of Cancer Risk in APC c.3920T>A (I1307K) Carriers: Evidence From a Cohort of Over 21,000 Healthy Individuals.” by CGA-IGC communications committee member @DanLiMD
➡️Full article in Gastroenterology @Gastrojournal. 👉🔗https://t.co/yw5DUMrPQk
#HereditaryGICancer
🧵
1/Welcome to the #CGAIGCJS Tweetorial on “Raising the Age for Starting Colonoscopy to 35 Years for Individuals With path_MSH6 Carriers May Lead to Missed Opportunities for Detecting Advanced Neoplasia in a Notable Percentage of Carriers.” by CGA-IGC communications committee member @DanLiMD
Full article in @AmJGastro https://t.co/zaV4p1mum0
🧵
#HereditaryGICancer
📢Curious about what’s new in the latest @NCCN Guideline updates for Pancreatic Cancer Screening? 🧐📄
➡️Thanks to our Communications Committee member Dylane Wineland, MS, LCGC, who put together an easy, at-a-glance overview highlighting the key changes and some important reminders to keep in mind.
📍Bookmark this resource for quick reference anytime you need it 👇
#PancreaticCancerAwarenessMonth
#HereditaryGICancer
1/Welcome to #CGAIGCJS Tweetorial on “Early-Onset Gastrointestinal Cancers: A Review” by CGA-IGC communications committee member @DanLiMD
Full article in @JAMA_current at https://t.co/kjUTiGZNyo
#HereditaryGICancer
🧵
#GUTImages from the paper by Yamada et al entitled
"Precision risk stratification of primary gastric cancer after eradication of H. pylori by a DNA methylation marker: a multicentre prospective study" via
https://t.co/XYIzRt1aLx
#GastricCancer
1/ Welcome to the #CGAIGCJS Tweetorial on:
"Germline Genetic Testing in Patients with Advanced Adenomas: A Prospective Study" by CGA-IGC Communications Committee member @annalstrang
📰Full article in @AGA_Gastro 👉https://t.co/0BHTuob42q
🧵
1/Welcome to #CGAIGCJS Tweetorial on “Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group” by #CGAIGC Communications Committee member @MLaszkowskaMD
➡️Full article in @CCR_AARC at 👉 https://t.co/UsPdSSiest
#HereditaryGICancer
@andrewdhawan@CharisEngMDPhD@liu_darren9@CancerMusketeer
🧵
Breaking post-#ASCO25 publication!
>1:8 #patients w/ #gastriccancer/#GC have PGVs on #germlinetesting
35% HRR genes #BRCA1, #BRCA2, etc
17% MMR genes #MLH2, #MSH2, etc
>91% of positive #patients had clinically actionable PGVs based on management guidelines or active #clinicaltrials
"These results support consideration of #genetictesting in all #patients w/ #GC..."
https://t.co/930m1CT8er @OphirGilad et al @UCCancerCenter@JCOPO_ASCO@ASCO@CGAIGC
#access #reducedisparities #universal #germlinetesting #precisionmedicine #precisiontherapy #clinicaltrials #precisionprevention
I know these faces look familiar!
Our past president, Bryson Katona, hosted the 2nd annual #CGAIGC "Pints and Polyps" Happy Hour during #DDW2025, providing a👍opportunity for our members to catch up, strengthen connections, & build community outside our annual meeting.
➡️Join us in St. Louis, MO, from October 9–11, 2025, for an unparalleled opportunity to learn, connect, & collaborate! 👉https://t.co/OsbyKS4KYw
📍Become a member & enjoy exclusive benefits—including discounted registration for our annual meeting and much more. Learn more 👉 https://t.co/A9SUvrdke8
#HereditaryGICancer #CGAIGC25
1/Welcome to #CGAIGCJS Tweetorial on “Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6/PMS2-Associated #LynchSyndrome” by CGA-IGC communications committee member @DanLiMD
Full article in @AmJGastro at DOI: 10.14309/ajg.0000000000003369 👉https://t.co/e4UT3chtAq
🧵
#HereditaryGICancer #RedJournal
Agreed. In 2025, MSI and MMR IHC should be used to decide who gets immune checkpoint blockade therapy - not to decide who gets germline genetic testing.
📈 H. pylori infection significantly elevates fecal calprotectin—often into ranges prompting IBD workup.
HP+ kids had higher FC & were more likely to undergo colonoscopy.
#pediatrics#pedsgi
🔗 https://t.co/w7H6lK62RQ
🧵1/
🚨 Just out: the PLSD's biggest prospective study yet on Lynch syndrome & colorectal cancer (CRC) surgery.
What’s the real risk of a second CRC—and can surgery prevent it?
Spoiler: Prior CRC = higher risk. Extended surgery = game changer. 👇
🔗 https://t.co/nKmvdFAJrS
1/Welcome to #CGAIGCJS Tweetorial on "@AmerGastroAssn Clinical Practice Update on Screening & Surveillance in Individuals at Increased Risk for #GastricCancer in the United States: Expert Review” by #CGAIGC Comms Cttee member @MLaszkowskaMD
➡️Full article in @AGA_Gastro at 👉https://t.co/tfVKqNZH8D
#HereditaryGICancer
🧵